Your browser doesn't support javascript.
loading
Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitment.
van den Ham, Henk-Jan; Cooper, Jason D; Tomasik, Jakub; Bahn, Sabine; Aerts, Joeri L; Osterhaus, Albert D M E; Gruters, Rob A; Andeweg, Arno C.
Affiliation
  • van den Ham HJ; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Cooper JD; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Tomasik J; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Bahn S; Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Aerts JL; Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
  • Osterhaus ADME; Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Gruters RA; Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Andeweg AC; Research Institute for Infectious Diseases and Zoonoses, Veterinary University Hannover, Hannover, Germany.
PLoS One ; 13(2): e0192278, 2018.
Article in En | MEDLINE | ID: mdl-29389978
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dendritic Cells / HIV Infections / Anti-HIV Agents / Immunity, Cellular / Neutrophils Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dendritic Cells / HIV Infections / Anti-HIV Agents / Immunity, Cellular / Neutrophils Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Year: 2018 Type: Article